Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Novavax Inc (NVAX) – Novavax Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novavax (NVAX) stock trades at $8.63, up 2.86% on the day, with technical indicators showing a bullish moving average signal. The company reported a surprise profit in Q4 2025, beating expectations, and has transitioned to a royalty-driven model with a high gross margin of 93.5%. However, it faces negative shareholder equity and activist investor pressure from Shah Capital.
The outlook is mixed: strong analyst consensus (74% buy rating) and a $17.50 price target suggest significant upside, but risks include a shareholder revolt, negative cash flow trends, and the challenge of sustaining profitability post-COVID vaccine boom. The stock's valuation appears low on P/E and P/S metrics, but high leverage and execution risks remain.
Read full analysis

Key Stats

  • Market Cap
    $1.42B
  • Sector
    Health
  • 3M Drawdown
    -31.19%
  • Enterprise Value
    $929.64M
  • Dividend Yield
    -
  • Trading Activity
    96% Buy | 4% Sell
  • Typical Hold Time
    58 days
$8.7
52W Low: $5.95
07 May 2025
52W High: $11.19
26 Feb 2026

Novavax Inc (NVAX) is currently valued at a market capitalization of $1.42B, with an enterprise value of $929.64M. Over the past 52 weeks, Novavax Inc has traded between a low of $5.95 and a high of $11.19, highlighting its annual price range. Over the past three months, Novavax Inc has recorded a drawdown of -31.19%, reflecting recent price volatility. On average, investors hold Novavax Inc for approximately 58 days, indicating typical investor behavior on the platform.

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.


Technical Indicators
|
|
|
Overall Summary
Bearish (4)Neutral (8)Bullish (15)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $1.42B
  • Sector
    Health
  • 3M Drawdown
    -31.19%
  • Enterprise Value
    $929.64M
  • Dividend Yield
    -
  • Trading Activity
    96% Buy | 4% Sell
  • Typical Hold Time
    58 days
$8.7
52W Low: $5.95
07 May 2025
52W High: $11.19
26 Feb 2026

Novavax Inc (NVAX) is currently valued at a market capitalization of $1.42B, with an enterprise value of $929.64M. Over the past 52 weeks, Novavax Inc has traded between a low of $5.95 and a high of $11.19, highlighting its annual price range. Over the past three months, Novavax Inc has recorded a drawdown of -31.19%, reflecting recent price volatility. On average, investors hold Novavax Inc for approximately 58 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!